Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nektar Therapeutics (NKTR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nektar Therapeutics. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 906709.
Total stock buying since 2015: $1,380,381.
Total stock sales since 2015: $232,957,638.
Total stock option exercises since 2015: $64,061,600.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 93,989 | $213,902 | 0 | $0 |
| 2024 | 0 | $0 | 383,431 | $446,447 | 0 | $0 |
| 2023 | 0 | $0 | 198,698 | $243,015 | 0 | $0 |
| 2022 | 0 | $0 | 287,002 | $1,338,751 | 0 | $0 |
| 2021 | 0 | $0 | 1,014,438 | $19,214,807 | 857,844 | $8,374,525 |
| 2020 | 0 | $0 | 272,486 | $5,487,307 | 147,500 | $1,286,775 |
| 2019 | 15,000 | $259,200 | 759,188 | $22,794,714 | 719,119 | $6,026,072 |
| 2018 | 5,000 | $290,431 | 1,255,625 | $101,982,187 | 1,060,964 | $11,098,812 |
| 2017 | 35,000 | $628,250 | 2,330,497 | $52,704,314 | 2,405,467 | $22,656,144 |
| 2016 | 15,000 | $202,500 | 687,748 | $10,451,012 | 786,583 | $3,364,205 |
| 2015 | 0 | $0 | 1,435,718 | $18,081,182 | 1,563,334 | $11,255,067 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-08 | Chess Robert (Director) | Sale | 8,000 | 24.58 | 196,640 |
| 2020-07-08 | Chess Robert (Director) | Option Ex | 8,000 | 9.24 | 73,920 |
| 2020-05-19 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 2,000 | 22.62 | 45,240 |
| 2020-05-18 | Wilson Mark Andrew (SVP & General Counsel) | Sale | 1,529 | 22.51 | 34,417 |
| 2020-05-18 | Zalevsky Jonathan (Chief R&D Officer) | Sale | 4,558 | 22.51 | 102,600 |
| 2020-05-18 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 1,367 | 22.51 | 30,771 |
| 2020-05-18 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 5,727 | 22.51 | 128,914 |
| 2020-05-18 | Robin Howard W (President & CEO) | Sale | 8,968 | 22.51 | 201,869 |
| 2020-04-15 | Chess Robert (Director) | Sale | 8,000 | 18.69 | 149,520 |
| 2020-04-15 | Chess Robert (Director) | Option Ex | 8,000 | 9.24 | 73,920 |
| 2020-03-11 | Chess Robert (Director) | Sale | 8,000 | 17.05 | 136,360 |
| 2020-03-11 | Chess Robert (Director) | Option Ex | 8,000 | 9.24 | 73,920 |
| 2020-02-18 | Zalevsky Jonathan (Chief R&D Officer) | Sale | 4,774 | 22.35 | 106,698 |
| 2020-02-18 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 1,394 | 22.35 | 31,155 |
| 2020-02-18 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 5,938 | 22.35 | 132,714 |
| 2020-02-18 | Robin Howard W (President & CEO) | Sale | 8,448 | 22.35 | 188,812 |
| 2020-02-12 | Chess Robert (Director) | Sale | 8,000 | 23.52 | 188,160 |
| 2020-02-12 | Chess Robert (Director) | Option Ex | 8,000 | 9.24 | 73,920 |
| 2020-02-06 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 37,500 | 22.78 | 854,250 |
| 2020-02-06 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 37,500 | 7.21 | 270,375 |
| 2019-12-18 | Whitfield Roy A (Director) | Option Ex | 10,000 | 9.24 | 92,400 |
| 2019-11-18 | Zalevsky Jonathan (Chief R&D Officer) | Sale | 3,960 | 17.97 | 71,161 |
| 2019-11-18 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 2,713 | 17.97 | 48,752 |
| 2019-11-18 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 8,863 | 17.97 | 159,268 |
| 2019-11-18 | Robin Howard W (President & CEO) | Sale | 13,556 | 17.97 | 243,601 |
| 2019-11-13 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 25,000 | 19.79 | 494,750 |
| 2019-11-13 | Labrucherie Gil M (SVP, COO & CFO) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-10-17 | Robin Howard W (President & CEO) | Sale | 33,333 | 17.68 | 589,327 |
| 2019-10-17 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-10-16 | Robin Howard W (President & CEO) | Sale | 33,334 | 17.48 | 582,678 |
| 2019-10-16 | Robin Howard W (President & CEO) | Option Ex | 33,334 | 7.21 | 240,338 |
| 2019-10-15 | Labrucherie Gil M (SVP, COO & CFO) | Sale | 25,000 | 15.83 | 395,750 |
| 2019-10-15 | Labrucherie Gil M (SVP, COO & CFO) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-10-15 | Robin Howard W (President & CEO) | Sale | 33,333 | 16.76 | 558,661 |
| 2019-10-15 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-09-30 | Ajer Jeffrey Robert (Director) | Sale | 2,375 | 18.06 | 42,892 |
| 2019-09-27 | Lingnau Lutz (Director) | Sale | 3,000 | 17.84 | 53,520 |
| 2019-09-27 | Chess Robert (Director) | Sale | 4,000 | 17.99 | 71,960 |
| 2019-09-20 | Ajer Jeffrey Robert (Director) | Sale | 2,250 | 20.24 | 45,540 |
| 2019-09-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 25,000 | 20.52 | 513,000 |
| 2019-09-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-09-05 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Buy | 15,000 | 17.28 | 259,200 |
| 2019-08-26 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 30,000 | 16.31 | 489,299 |
| 2019-08-23 | Robin Howard W (President & CEO) | Option Ex | 30,000 | 16.31 | 489,299 |
| 2019-08-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 3,245 | 18.15 | 58,896 |
| 2019-08-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 1,809 | 18.15 | 32,833 |
| 2019-08-16 | Nicholson John (SVP & Chief Operating Officer) | Sale | 3,819 | 18.15 | 69,314 |
| 2019-08-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 5,063 | 18.15 | 91,893 |
| 2019-08-16 | Robin Howard W (President & CEO) | Sale | 12,551 | 18.15 | 227,800 |
| 2019-08-14 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 25,000 | 17.79 | 444,750 |
| 2019-08-14 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-07-25 | Robin Howard W (President & CEO) | Sale | 33,333 | 29.65 | 988,323 |
| 2019-07-25 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-07-24 | Robin Howard W (President & CEO) | Sale | 33,334 | 32.11 | 1,070,354 |
| 2019-07-24 | Robin Howard W (President & CEO) | Option Ex | 33,334 | 7.21 | 240,338 |
| 2019-07-23 | Robin Howard W (President & CEO) | Sale | 33,333 | 32.10 | 1,069,989 |
| 2019-07-23 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-07-10 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 25,000 | 34.57 | 864,250 |
| 2019-07-10 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-07-08 | Lingnau Lutz (Director) | Sale | 10,000 | 34.63 | 346,300 |
| 2019-07-08 | Lingnau Lutz (Director) | Option Ex | 10,000 | 9.24 | 92,400 |
| 2019-06-17 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 25,000 | 33.71 | 842,750 |
| 2019-06-17 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 25,000 | 7.21 | 180,250 |
| 2019-05-23 | Robin Howard W (President & CEO) | Sale | 33,333 | 32.69 | 1,089,655 |
| 2019-05-23 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-05-22 | Robin Howard W (President & CEO) | Sale | 33,334 | 33.38 | 1,112,688 |
| 2019-05-22 | Robin Howard W (President & CEO) | Option Ex | 33,334 | 7.21 | 240,338 |
| 2019-05-21 | Robin Howard W (President & CEO) | Sale | 33,333 | 32.93 | 1,097,655 |
| 2019-05-21 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-05-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 3,461 | 31.37 | 108,571 |
| 2019-05-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 2,449 | 31.37 | 76,825 |
| 2019-05-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 1,928 | 31.37 | 60,481 |
| 2019-05-16 | Nicholson John (SVP & Chief Operating Officer) | Sale | 4,077 | 31.37 | 127,895 |
| 2019-05-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 3,767 | 31.37 | 118,170 |
| 2019-05-16 | Robin Howard W (President & CEO) | Sale | 13,383 | 31.37 | 419,824 |
| 2019-03-08 | Greer R Scott (Director) | Option Ex | 10,000 | 5.14 | 51,400 |
| 2019-02-21 | Robin Howard W (President & CEO) | Sale | 33,333 | 41.01 | 1,366,986 |
| 2019-02-21 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-02-20 | Robin Howard W (President & CEO) | Sale | 33,334 | 43.20 | 1,440,028 |
| 2019-02-20 | Robin Howard W (President & CEO) | Option Ex | 33,334 | 7.21 | 240,338 |
| 2019-02-19 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 3,310 | 42.39 | 140,310 |
| 2019-02-19 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 2,386 | 42.39 | 101,142 |
| 2019-02-19 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 1,808 | 42.39 | 76,641 |
| 2019-02-19 | Nicholson John (SVP & Chief Operating Officer) | Sale | 3,822 | 42.39 | 162,014 |
| 2019-02-19 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 3,592 | 42.39 | 152,264 |
| 2019-02-19 | Robin Howard W (President & CEO) | Sale | 42,215 | 42.35 | 1,788,016 |
| 2019-02-19 | Robin Howard W (President & CEO) | Option Ex | 33,333 | 7.21 | 240,330 |
| 2019-02-04 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 16,119 | 42.16 | 679,577 |
| 2019-02-04 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 16,119 | 10.69 | 172,312 |
| 2019-01-28 | Nicholson John (SVP & Chief Operating Officer) | Sale | 63,000 | 42.82 | 2,697,660 |
| 2019-01-28 | Nicholson John (SVP & Chief Operating Officer) | Option Ex | 63,000 | 10.69 | 673,470 |
| 2018-11-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 4,524 | 38.25 | 173,043 |
| 2018-11-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 4,694 | 38.25 | 179,545 |
| 2018-11-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 4,016 | 38.25 | 153,612 |
| 2018-11-16 | Nicholson John (SVP & Chief Operating Officer) | Sale | 5,982 | 38.25 | 228,811 |
| 2018-11-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 6,515 | 38.25 | 249,198 |
| 2018-11-16 | Robin Howard W (President & CEO) | Sale | 15,326 | 38.25 | 586,219 |
| 2018-09-20 | Ajer Jeffrey Robert (Director) | Sale | 6,750 | 56.76 | 383,130 |
| 2018-09-20 | Lingnau Lutz (Director) | Sale | 9,000 | 56.98 | 512,820 |
| 2018-09-19 | Chess Robert (Director) | Sale | 4,500 | 56.81 | 255,645 |
| 2018-09-04 | Greer R Scott (Director) | Sale | 10,000 | 67.39 | 673,900 |
| 2018-09-04 | Greer R Scott (Director) | Option Ex | 10,000 | 5.14 | 51,400 |
| 2018-08-21 | Winger Dennis L (Director) | Sale | 15,000 | 60.30 | 904,500 |
| 2018-08-21 | Winger Dennis L (Director) | Option Ex | 15,000 | 14.26 | 213,900 |
| 2018-08-17 | Winger Dennis L (Director) | Sale | 15,000 | 59.62 | 894,300 |
| 2018-08-17 | Winger Dennis L (Director) | Option Ex | 15,000 | 14.26 | 213,900 |
| 2018-08-14 | Winger Dennis L (Director) | Sale | 17,125 | 60.15 | 1,030,068 |
| 2018-08-13 | Winger Dennis L (Director) | Sale | 17,125 | 61.04 | 1,045,310 |
| 2018-06-27 | Robin Howard W (President & CEO) | Sale | 43,333 | 47.39 | 2,053,550 |
| 2018-06-27 | Robin Howard W (President & CEO) | Option Ex | 43,333 | 10.69 | 463,229 |
| 2018-06-26 | Robin Howard W (President & CEO) | Sale | 43,333 | 49.36 | 2,138,916 |
| 2018-06-26 | Robin Howard W (President & CEO) | Option Ex | 43,333 | 10.69 | 463,229 |
| 2018-06-25 | Robin Howard W (President & CEO) | Sale | 43,334 | 51.82 | 2,245,567 |
| 2018-06-25 | Robin Howard W (President & CEO) | Option Ex | 43,334 | 10.69 | 463,240 |
| 2018-06-06 | Greer R Scott (Director) | Sale | 8,600 | 60.00 | 516,000 |
| 2018-06-06 | Greer R Scott (Director) | Option Ex | 8,600 | 5.14 | 44,204 |
| 2018-06-06 | Whitfield Roy A (Director) | Buy | 3,400 | 59.44 | 202,079 |
| 2018-06-05 | Chess Robert (Director) | Sale | 10,000 | 55.16 | 551,600 |
| 2018-06-05 | Chess Robert (Director) | Option Ex | 10,000 | 14.26 | 142,600 |
| 2018-06-05 | Whitfield Roy A (Director) | Buy | 1,600 | 55.22 | 88,352 |
| 2018-06-04 | Greer R Scott (Director) | Sale | 1,400 | 61.99 | 86,786 |
| 2018-06-04 | Greer R Scott (Director) | Option Ex | 1,400 | 5.14 | 7,196 |
| 2018-05-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 3,435 | 83.39 | 286,444 |
| 2018-05-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 4,060 | 83.39 | 338,563 |
| 2018-05-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 3,576 | 83.39 | 298,202 |
| 2018-05-16 | Nicholson John (SVP & Chief Operating Officer) | Sale | 4,917 | 83.39 | 410,028 |
| 2018-05-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 4,941 | 83.39 | 412,029 |
| 2018-05-16 | Robin Howard W (President & CEO) | Sale | 12,791 | 83.39 | 1,066,641 |
| 2018-05-03 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 30,000 | 82.86 | 2,485,800 |
| 2018-05-03 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 30,000 | 10.69 | 320,700 |
| 2018-05-03 | Chess Robert (Director) | Sale | 25,000 | 82.80 | 2,070,000 |
| 2018-05-03 | Chess Robert (Director) | Option Ex | 25,000 | 9.70 | 242,499 |
| 2018-05-03 | Robin Howard W (President & CEO) | Sale | 43,333 | 82.86 | 3,590,572 |
| 2018-05-03 | Robin Howard W (President & CEO) | Option Ex | 43,333 | 10.69 | 463,229 |
| 2018-05-02 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 30,000 | 85.63 | 2,568,900 |
| 2018-05-02 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 30,000 | 10.69 | 320,700 |
| 2018-05-02 | Robin Howard W (President & CEO) | Sale | 43,333 | 85.63 | 3,710,604 |
| 2018-05-02 | Robin Howard W (President & CEO) | Option Ex | 43,333 | 10.69 | 463,229 |
| 2018-05-01 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 30,000 | 83.65 | 2,509,500 |
| 2018-05-01 | Labrucherie Gil M (SVP & Chief Financial Officer) | Option Ex | 30,000 | 10.69 | 320,700 |
| 2018-05-01 | Robin Howard W (President & CEO) | Sale | 43,334 | 83.65 | 3,624,889 |
| 2018-05-01 | Robin Howard W (President & CEO) | Option Ex | 43,334 | 10.69 | 463,240 |
| 2018-04-17 | Whitfield Roy A (Director) | Option Ex | 30,000 | 14.26 | 427,800 |
| 2018-04-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 13,881 | 101.46 | 1,408,366 |
| 2018-04-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 13,881 | 10.69 | 148,387 |
| 2018-04-10 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 502 | 105.67 | 53,046 |
| 2018-04-10 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Option Ex | 502 | 7.21 | 3,619 |
| 2018-04-09 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 49,500 | 96.13 | 4,758,435 |
| 2018-04-09 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Option Ex | 49,500 | 7.21 | 356,895 |
| 2018-04-09 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 9,498 | 105.05 | 997,764 |
Insider trading activities including stock purchases, stock sales, and option exercises of NKTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nektar Therapeutics (symbol NKTR, CIK number 906709) see the Securities and Exchange Commission (SEC) website.